What is Clinitech Laboratory Ltd (544220) share price return in the past 10 years?

Data is not available for this company

What is the share price of Clinitech Laboratory Ltd (544220)?

Company share prices are keep on changing according to the market conditions. The current trading price of Clinitech Laboratory Ltd (544220) on 29-May-2026 16:59:59 at 16:59 is 37.80.

What is the P/E ratio of Clinitech Laboratory?

The latest standalone P/E ratio of Clinitech Laboratory as of 29-May-2026 is 20.40.

What is the P/B ratio of Clinitech Laboratory Ltd (544220)?

The latest standalone P/B ratio of Clinitech Laboratory Ltd (544220) as of 29-May-2026 is 0.98.

What is the 52-week high and low of Clinitech Laboratory Ltd (544220)?

The 52-week high of Clinitech Laboratory Ltd (544220) is Rs. 57.00 and the 52-week low is Rs. 28.55.

Clinitech Laboratory Ltd (544220) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Clinitech Laboratory Ltd (544220)
Brand: Clinitech Laboratory

Clinitech Laboratory Ltd (544220)

Key Metrics

Valuation Multiples

Market Cap

₹9 Cr.

Current Price

₹37.8

52-Week Low / High

₹29 / 57

TTM EPS

₹1.9

TTM Sales

₹9.5 Cr.

Book Value per Share

₹38.7

P/E Ratio

20.40

Lower than its 5-year historical median

Industry PE

88.3

Price to Book (P/B)

0.98

Lower than its 5-year historical median

Price to Sales (P/S)

0.91

Lower than its 5-year historical median

EV/EBITDA

4.69

Lower than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

6.38%

Underperforms industry median

Return on Capital Employed (ROCE)

9.21%

Underperforms industry median

Return on Assets (ROA)

4.94%

Operating Profit Margin

10.1%

Net Profit Margin

4.79%

Gross Profit Margin

12.2%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

28.59%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-17%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

5.41%

Asset Quality

Promoter Holding

64.20%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹7 Cr.

Equity

₹2.3 Cr.

Face Value

₹10

All Time Low / High

₹28.55 / 120.75

Clinitech Laboratory stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Clinitech Laboratory Ltd a good quality company?

Clinitech Laboratory Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Clinitech Laboratory Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Clinitech Laboratory Ltd vs industry peers?

Clinitech Laboratory Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 1.38%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Clinitech Laboratory Ltd?

Promoters hold 64.20% of the Clinitech Laboratory Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Clinitech Laboratory Ltd over the last decade?

Over the last 1 year(s), the stock has delivered a CAGR of -5.41% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	32.5%	32.6%	30.4%	15.3%	9.2%	-
Value Creation Index ⓘ	1.3	1.3	1.2	0.1	-0.3	-
Growth Parameters ⓘ
Sales ⓘ	4.6	6.4	6.4	6.4	8.2	9
Sales YoY Gr.	-	40.2%	-0.5%	0.8%	28.6%	-
Adj EPS ⓘ	2.7	3.4	4.1	2.2	1.5	1.9
YoY Gr.	-	27.6%	19.6%	-47.2%	-29.6%	-
BVPS (₹) ⓘ	9.3	12.3	15.9	21.1	38.7	38.7
Adj Net Profit ⓘ	0.4	0.5	0.6	0.4	0.4	0
Cash Flow from Ops. ⓘ	0.4	1	1.3	-1.3	-0.9	-
Debt/CF from Ops. ⓘ	1.4	0.9	0.8	-0.7	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	8.9%	28.6%
Adj EPS ⓘ	NA	NA	-23.7%	-29.6%
BVPSⓘ	NA	NA	46.4%	83.2%
Share Price	-	-	-	4.8%

Key Financial Parameters ⓘ

	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	28.9	31.7	29	12.3	5.6	4.8
Op. Profit Mgn % ⓘ	18.2	16.7	21.5	15.6	10.1	NAN
Net Profit Mgn % ⓘ	8.8	8	9.7	5.7	4.2	4.5
Debt to Equity ⓘ	0.4	0.5	0.4	0.2	0	-
Working Cap Days ⓘ	0	74	71	91	139	0
Cash Conv. Cycle ⓘ	0	-4	-4	16	39	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	4.55	6.38	6.35	6.40	8.23
Operating Expenses ⓘ +	3.73	5.32	4.98	5.40	7.40
Manufacturing Costs	0.78	1.14	0.92	1.12	1.80
Material Costs	1.02	1.45	1.17	1.10	1.56
Employee Cost	0.92	1.38	1.55	1.92	2.38
Other Costs ⓘ	1	1.35	1.34	1.26	1.66
Operating Profit ⓘ	0.83	1.07	1.36	1	0.83
Operating Profit Margin (%)	18.2%	16.7%	21.5%	15.6%	10.1%
Other Income ⓘ +	0.04	0.07	0.02	0.04	0.23
Exceptional Items ⓘ	0	0	0	0	0
Interest ⓘ	0.08	0.06	0.07	0.09	0.06
Depreciation ⓘ	0.25	0.38	0.45	0.44	0.45
Profit Before Tax ⓘ	0.55	0.70	0.86	0.51	0.55
Tax ⓘ	0.14	0.19	0.25	0.13	0.16
Profit After Tax	0.40	0.51	0.61	0.37	0.39
PAT Margin (%)	8.8%	8.0%	9.7%	5.8%	4.8%
Adjusted EPS (₹)	2.7	3.4	4.1	2.2	1.7
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%

Valuation of Clinitech Laboratory - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	1.39	1.85	2.38	3.55	8.83
Share Capital ⓘ	0.67	1.50	1.50	1.68	2.28
Reserves ⓘ	0.72	0.35	0.88	1.87	6.55
Debt +	0.48	0.81	0.95	0.81	0
Long Term Debt	0.48	0.36	0.28	0.23	0
Short Term Debt	0	0.46	0.67	0.58	0
Minority Interest	0	0	0	0	0
Trade Payables	0.46	0.52	0.40	0.35	0.63
Others Liabilities ⓘ	0.31	0.40	2.14	0.74	1.09
Total Liabilities ⓘ	2.64	3.58	5.88	5.44	10.55
Fixed Assets
Net Fixed Assets ⓘ +	0.84	1.65	1.33	1.71	2.12
Gross Block	2.45	3.52	3.65	4.47	5.33
Accumulated Depreciation	1.61	1.87	2.32	2.76	3.21
CWIP ⓘ	0.08	0.41	0.56	0.94	1.01
Investments ⓘ	0.09	0.14	2.02	0.07	0.07
Inventories	0.09	0.16	0.14	0.28	0.53
Trade Receivables	0.56	0.36	0.49	0.60	1.54
Cash Equivalents ⓘ	0.32	0.10	0.78	0.70	3.07
Others Assets ⓘ	0.66	0.76	0.55	1.13	2.19
Total Assets ⓘ	2.64	3.58	5.88	5.44	10.55

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0.38	0.96	1.25	-1.28	-0.88
PBT ⓘ	0.55	0.70	0.86	0.51	0.55
Adjustment ⓘ	0.17	0.31	0.41	0.50	0.29
Changes in Working Capital ⓘ	-0.18	0.15	0.28	-2.14	-1.57
Tax Paid ⓘ	-0.15	-0.21	-0.30	-0.14	-0.16
Cash Flow From Investing Activity ⓘ +	0.54	-1.47	-0.65	0.75	-0.73
Capex	-0.19	-1.51	-0.28	-1.21	-0.86
Net Investments	0.59	-0.05	-1.88	1.95	0
Others ⓘ	0.14	0.10	1.51	0.01	0.13
Cash Flow From Financing Activity ⓘ +	-0.88	0.29	0.09	0.45	3.98
Net Proceeds from Shares ⓘ	0	0	0	0.68	4.89
Net Proceeds from Borrowing ⓘ	-0.55	-0.12	-0.08	-0.05	-0.29
Interest Paid ⓘ	-0.08	-0.06	-0.06	-0.07	-0.04
Dividend Paid ⓘ	0	0	0	0	0
Others ⓘ	-0.25	0.47	0.22	-0.12	-0.58
Net Cash Flow ⓘ	0.04	-0.22	0.68	-0.08	2.37

Financial Ratio

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	28.94	31.66	29	12.52	6.38
ROCE (%)	32.47	32.61	30.39	15.28	9.21
Asset Turnover Ratio	1.72	2.05	1.34	1.13	1.03
PAT to CFO Conversion(x)	0.95	1.88	2.05	-3.46	-2.26
Working Capital Days
Receivable Days	44.80	26.40	24.50	31	47.40
Inventory Days	7.10	7	8.50	12.10	18
Payable Days	164.90	123.40	143.70	123.30	114

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Clinitech Laboratory Ltd FAQs

The current trading price of Clinitech Laboratory on 29-May-2026 16:59 is ₹37.80.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-May-2026 the market cap of Clinitech Laboratory stood at ₹8.63 Cr

The latest P/E ratio of Clinitech Laboratory as of 28-May-2026 is 20.40.

The latest P/B ratio of Clinitech Laboratory as of 28-May-2026 is 0.98.

The 52-week high of Clinitech Laboratory is ₹57.00 and the 52-week low is ₹28.55.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Clinitech Laboratory is ₹9.47 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Clinitech Laboratory Ltd is a average quality company.

The key valuation ratios of Clinitech Laboratory Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Clinitech Laboratory Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Clinitech Laboratory Ltd

The company was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 under the Companies Act, 1956 with the Registrar of Companies, Mumbai. The status of the company was changed to public limited and the name of the company was changed to Clinitech Laboratory Limited vide Special Resolution dated July 24, 2023 pursuant to conversion of the Company into public limited Company. The fresh certificate of incorporation consequent to conversion was issued on August 25, 2023 by the Registrar of Companies, Mumbai.

The company is a provider of diagnostic and healthcare tests and services through chain of several diagnostic centers in and around Thane and Navi Mumbai. Its Promoters have many years of experience in diagnostic business. It conducts lakhs of tests per year in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited labs equipped with modern technology and high-end equipment. It conducts various tests at its centres which are classified under various heads as under: Biochemistry tests; Immunology tests; Hematology tests; Molecular Biology tests; Serology tests; Microbiology tests; and Histopathology tests.

Business area of the company

The company is one of the most trusted diagnostic centers & pathology labs.

Major Events and Milestones

2010: Incorporation of the company.
2012: Established new Lab at Kalyan.
2016: NABL Accreditation at Airoli Centre.
2018: Established new Lab at Thane.
2021: NABL Accreditation for SARS-COV-2 testing.
2021: Signed up agreements for Diagnostic Centre at Kharghar.
2022: Signed up agreements for Diagnostic Centre at Panvel / Badlapur.
2023: Converted Company to Limited.
2023: Established new Lab at Murbad and Panvel.

Clinitech Laboratory Ltd (544220)

Clinitech Laboratory Ltd (544220)

Clinitech Laboratory stock performance